Showing results (501-510 of 1,983) with videos related to
Sort By:
Pageof 199
The Lancet. Neurology|January 11, 2011
Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trialFrançois Chollet, Jean Tardy, Jean-François Albucher, et al.The Lancet. Neurology|January 25, 2011
Mechanisms of epileptogenesis and potential treatment targetsAsla Pitkänen, Katarzyna LukasiukThe Lancet. Neurology|February 26, 2011
Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron diseaseThomas Philips, Wim RobberechtThe Lancet. Neurology|February 26, 2011
The sirtuin pathway in ageing and Alzheimer disease: mechanistic and therapeutic considerationsDavid J Bonda, Hyoung-Gon Lee, Antoni Camins, et al.The Lancet. Neurology|August 21, 2010
Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyondAlexandra DurrThe Lancet. Neurology|July 24, 2010
Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatmentRalf Baron, Andreas Binder, Gunnar WasnerThe Lancet. Neurology|July 24, 2010
A neurological perspective on mitochondrial diseaseRobert McFarland, Robert W Taylor, Douglass M TurnbullThe Lancet. Neurology|August 3, 2010
The effects of hypertension on the paediatric brain: a justifiable concernMadhu Sharma, Juan C Kupferman, Yuri Brosgol, et al.The Lancet. Neurology|July 13, 2010
Effects of antihypertensive treatment after acute stroke in the Continue or Stop Post-Stroke Antihypertensives Collaborative Study (COSSACS): a prospective, randomised, open, blinded-endpoint trialThompson G Robinson, John F Potter, Gary A Ford, et al.The Lancet. Neurology|July 13, 2010
Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trialRaju Kapoor, Julian Furby, Thomas Hayton, et al.Pageof 199